Biogen Idec: Tecfidera not cause of patient's death

Share this article:

Biogen Idec said the death of a patient in July was not caused by its MS drug Tecfidera, reported the Wall Street Journal, which says the patient's physician came to this conclusion.

The patient had taken Tecfidera but stopped her regimen two-and-a-half weeks before she died, due to side effects including vomiting and diarrhea. Biogen Idec told Pharmalot at the time that this was important to note because the death was not “GI related.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters